CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4266-4280

  Alexander, Kylie A ^a   Flynn, Ryan ^b   Lineburg, Katie E ^a   Kuns, Rachel D ^a   Teal, Bianca E ^a   Olver, Stuart D ^a   Lor, Mary ^a   Raffelt, Neil C ^a   Koyama, Motoko ^a   Leveque, Lucie ^a   Le Texier, Laetitia ^a   Melino, Michelle ^a   Markey, Kate A ^a   Varelias, Antiopi ^a   Engwerda, Christian ^a   Serody, Jonathan S ^c   Janela, Baptiste ^d   Ginhoux, Florent ^d   Clouston, Andrew D ^e   Blazar, Bruce R ^b   Hill, Geoffrey R ^a,f   MacDonald, Kelli P A ^a   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d AGENCY FOR SCIENCE   (Singapore)

^e Envoi Pathology   (Australia)

^f ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD206 ANTIGEN; COLONY STIMULATING FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; MANNOSE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; COLONY STIMULATING FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRONCHIOLITIS OBLITERANS; CELL INFILTRATION; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GRAFT RECIPIENT; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG COMPLIANCE; LUNG FUNCTION TEST; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCLERODERMA; SIGNAL TRANSDUCTION; SKIN FIBROSIS; SKIN INFILTRATE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL SEPARATION; CHEMISTRY; CYTOLOGY; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; GRAFT VERSUS HOST REACTION; LUNG; LUNG DISEASE; MALE; METABOLISM; PATHOLOGY; SKIN; STEM CELL TRANSPLANTATION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL SEPARATION; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; INTERLEUKIN-17; LUNG; LUNG DISEASES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCYTES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; SKIN; STEM CELL TRANSPLANTATION;

EID: 84907495480     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75935     Document Type: Article

References (55)

1. Bensinger WI, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patient with hematologic cancers. N Engl J Med. 2001;344(3):175-181.
2. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953-964.
3. Bonifer C, Hume DA. The transcriptional regulation of the Colony-Stimulating Factor 1 Receptor (csf1r) gene during hematopoiesis. Front Biosci. 2008;13:549-560.
4. Stanley ER, et al. Biology and action of colony - stimulating factor-1. Mol Reprod Dev. 1997;46(1):4-10.
5. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35.
6. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677-686.
7. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008;8(7):533-544.
8. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176(1):287-292.
9. Hill GR, et al. Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood. 2010;116(5):819-828.
10. Duffield JS, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115(1):56-65.
11. Pesce JT, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5(4):e1000371.
12. Murray LA, et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol. 2011;43(1):154-162.
13. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant. 2008;23(3):842-852.
14. Wang H, et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest. 2006;116(8):2105-2114.
15. Stratis A, et al. Pathogenic role for skin macrophages in a mouse model of keratinocyteinduced psoriasis-like skin inflammation. J Clin Invest. 2006;116(8):2094-2104.
16. Nishiwaki S, et al. Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Blood. 2009;114(14):3113-3116.
17. Shimizu K, et al. Increased serum levels of soluble CD163 in patients with scleroderma. Clin Rheumatol. 2012;31(7):1059-1064.
18. Juniantito V, et al. Immunophenotypical characterization of macrophages in rat bleomycin-induced scleroderma. Vet Pathol. 2013;50(1):76-85.
19. Higashi-Kuwata N, et al. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther. 2010;12(4):R128.
20. Sun L, et al. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol. 2011;300(3):L341-L353.
21. Sasmono RT, et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood. 2003;101(3):1155-1163.
22. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71-82.
23. Greter M, et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity. 2012;37(6):1050-1060.
24. Robb L, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common β subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A. 1995;92(21):9565-9569.
25. Lloyd CM, Dorf ME, Proudfoot A, Salant DJ, Gutierrez-Ramos JC. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol. 1997;62(5):676-680.
26. Hasegawa M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clin Exp Immunol. 1999;117(1):159-165.
27. Distler JH, et al. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Ar thritis Rheum. 2006;54(1):214-225.
28. Yamamoto T, Eckes B, Hartmann K, Krieg T. Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. J Dermatol Sci. 2001;26(2):133-139.
29. Scala E, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol. 2004;138(3):540-546.
30. MacDonald KP, et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood. 2010;116(19):3955-3963.
31. Banovic T, et al. TGF-β in allogeneic stem cell transplantation: friend or foe? Blood. 2005;106(6):2206-2214.
32. Srinivasan M, et al. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. Blood. 2012;119(6):1570-1580.
33. Ginhoux F, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841-845.
34. Bogunovic M, et al. Origin of the lamina propria dendritic cell network. Immunity. 2009;31(3):513-525.
35. Varol C, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity. 2009;31(3):502-512.
36. Sunderkotter C, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol. 2004;172(7):4410-4417.
37. Hashimoto D, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38(4):792-804.
38. Yona S, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38(1):79-91.
39. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol. 2001;13(7):777-784.
40. Luckey SW, Petersen DR. Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp Mol Pathol. 2001;71(3):226-240.
41. Tacke F, Ginhoux F, Jakubzick C, Van Rooijen N, Merad M, Randolph GJ. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med. 2006;203(3):583-597.
42. Blazar BR, Aukerman SL, Vallera DA. Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants. Blood. 1992;79(6):1636-1642.
43. Praloran V, et al. Alterations in the expression of colony-stimulating factor-1 and its receptor during an acute graft-vs-host reaction in mice. J Immunol. 1990;145(10):3256-3261.
44. Hashimoto D, et al. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. J Exp Med. 2011;208(5):1069-1082.
45. Pyonteck SM, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19(10):1264-1272.
46. Dewar AL, et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood. 2005;105(8):3127-3132.
47. Magro L, et al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versushost disease. Blood. 2009;114(3):719-722.
48. Olivieri A, et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood. 2009;114(3):709-718.
49. De Masson A, et al. Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD. Blood. 2012;120(25):5089-5090.
50. Boring L, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 1997;100(10):2552-2561.
51. Kissenpfennig A, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654.
52. Burman AC, et al. IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood. 2007;110(3):1064-1072.
53. Cooke KR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 1996;88(8):3230-3239.
54. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 1997;90(8):3204-3213.
55. Panoskaltsis-Mortari A, Tram KV, Price AP, Wendt CH, Blazar BR. A new murine model for bronchiolitis obliterans post-bone marrow transplant. Am J Respir Crit Care Med. 2007;176(7):713-723.